113 related articles for article (PubMed ID: 370538)
1. CCNU, vinblastine, and delalutin therapy in renal cell carcinoma.
Vosika GJ; Ryan MJ; Fortuny IA; Meyer C; Kiang DT; Theologides A; Kennedy BJ
Med Pediatr Oncol; 1978; 5(1):89-91. PubMed ID: 370538
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer.
Hahn RG; Temkin NR; Savlov ED; Perlia C; Wampler GL; Horton J; Marsh J; Carbone PP
Cancer Treat Rep; 1978 Jul; 62(7):1093-5. PubMed ID: 356971
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of vinblastine-CCNU, triazinate, and dactinomycin in advanced renal cell cancer.
Hahn RG; Begg CB; Davis T
Cancer Treat Rep; 1981; 65(7-8):711-13. PubMed ID: 7018680
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of advanced renal cell carcinoma with vinblastine and CCNU.
Merrin C; Mittelman A; Fanous N; Walsman Z; Murphy GP
J Urol; 1975 Jan; 113(1):21-3. PubMed ID: 1113389
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vincristine, CCNU and methyl-CCNU at high level doses in an experimental murine renal adenocarcinoma model.
Williams PD; Kantor P; Murphy GP
Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):529-36. PubMed ID: 7255884
[TBL] [Abstract][Full Text] [Related]
6. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy of advanced renal cell cancer with CCNU and vinblastine.
Sommer HH; Fosså SD; Lien HH
Cancer Chemother Pharmacol; 1985; 14(3):277-8. PubMed ID: 3995687
[TBL] [Abstract][Full Text] [Related]
8. Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
Hahn DM; Schimpff SC; Ruckdeschel JC; Wiernik PH
Cancer Treat Rep; 1977 Nov; 61(8):1585-7. PubMed ID: 72603
[No Abstract] [Full Text] [Related]
9. A critical review of immunotherapy of disseminated renal adenocarcinoma.
Montie JE; Bukowski RM; James RE; Straffon RA; Stewart BH
J Surg Oncol; 1982 Sep; 21(1):5-8. PubMed ID: 7109637
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of renal cell carcinoma. 2. Single-agent therapy with CCNU].
Satomi Y; Takai S; Nakahashi M
Nihon Hinyokika Gakkai Zasshi; 1982 Nov; 73(11):1431-5. PubMed ID: 7154472
[No Abstract] [Full Text] [Related]
11. [Cis-dichlorodiammineplatinum, adriamycin and cyclophosphamide versus cis-dichlorodiammineplatinum, adriamycin, cyclophosphamide and CCNU in non-small cell carcinoma of the lung].
Sanz Ortiz J; Saiz García F
Med Clin (Barc); 1982 Nov 16-30; 79(9):403-6. PubMed ID: 6296560
[No Abstract] [Full Text] [Related]
12. Chemotherapy of advanced transitional cell carcinoma of the renal pelvis: report of 3 cases treated with vinblastine and chloroethyl-cyclohexyl-nitrosourea.
von Eyben F; Mattsson W; Glifberg I; Lindholm CE
J Urol; 1979 Mar; 121(3):367-8. PubMed ID: 430637
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of chemotherapeutic agents in a new murine renal carcinoma model.
Hrushesky WJ; Murphy GP
J Natl Cancer Inst; 1974 Apr; 52(4):1117-22. PubMed ID: 4826582
[No Abstract] [Full Text] [Related]
14. Evaluation of beta-2'-deoxythioguanosine combined with methyl-CCNU or mitomycin in advanced colorectal cancer. A Southwest Oncology Group study.
Gagliano RG; Panettiere FJ; Haas CD; Baker L; Hewlett J; Stuckey WJ; O'Bryan RM; Bottomley R; Heilburn LK
Cancer Clin Trials; 1981; 4(4):401-5. PubMed ID: 7318121
[TBL] [Abstract][Full Text] [Related]
15. [Chemotherapy of renal cell carcinoma. 2. Combined chemotherapy using ACNU and VBL].
Kobayashi M; Imai K; Nakai K; Kumasaka F; Suzuki T; Ito Y; Yamanaka H; Sugihara S
Hinyokika Kiyo; 1986 Mar; 32(3):375-83. PubMed ID: 3460318
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
[TBL] [Abstract][Full Text] [Related]
17. Methyl-CCNU, alone and in combination with vincristine, or vincristine and methotrexate, in advanced bronchogenic carcinoma.
Richards F; Cooper MR; Muss HB; White DR; Spurr CL
Cancer; 1976 Sep; 38(3):1077-82. PubMed ID: 953956
[TBL] [Abstract][Full Text] [Related]
18. MItomycin C, methyl-CCNU and 5-fluorouracil in the treatment of metastatic colorectal carcinoma.
Bonomi PD; Chandra G; Rossof AH; Klaassen D
Cancer Chemother Pharmacol; 1980; 5(1):39-42. PubMed ID: 7006846
[TBL] [Abstract][Full Text] [Related]
19. Lomustine treatment of metastatic renal cell carcinoma.
Mittelman A; Albert DJ; Murphy GP
JAMA; 1973 Jul; 225(1):32-5. PubMed ID: 4740302
[No Abstract] [Full Text] [Related]
20. Chemotherapy for adenocarcinoma of the lung with 5-fluorouracil, cyclophosphamide, and CCNU (FCC).
Bedikian AY; Staab R; Livingston R; Valdivieso M; Burgess MA; Bodey GP
Cancer; 1979 Sep; 44(3):858-63. PubMed ID: 476597
[No Abstract] [Full Text] [Related]
[Next] [New Search]
